Log in

BioSolar Stock Forecast, Price & News

0.00 (0.00 %)
(As of 09/24/2020 12:00 AM ET)
Today's Range
Now: $0.01
50-Day Range
MA: $0.01
52-Week Range
Now: $0.01
Volume10.88 million shs
Average Volume6.55 million shs
Market Capitalization$4.33 million
P/E Ratio0.04
Dividend YieldN/A
BioSolar, Inc. develops technologies and materials for storing electrical energy produced by photovoltaic solar modules. It offers BioBacksheet, a green back sheet for photovoltaic solar modules. The company also focuses on developing silicon alloy based anode materials for lithium-ion batteries. It plans to engage with lithium-ion battery manufacturers and identify licensing partners in the electric vehicles, consumer electronics, and grid electrical storage industries to market its products. The company was formerly known as BioSolar Labs, Inc. and changed its name to BioSolar, Inc. in June 2006. BioSolar, Inc. was founded in 2006 and is headquartered in Santa Clarita, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.83 out of 5 stars

Industry, Sector and Symbol

Industry Unsupported plastics film & sheet
Current SymbolOTCMKTS:BSRC



Sales & Book Value

Annual SalesN/A
Cash Flow$0.03 per share
Book Value($0.09) per share


Net Income$4.12 million


Market Cap$4.33 million
Next Earnings Date11/5/2020 (Estimated)
OptionableNot Optionable
0.00 (0.00 %)
(As of 09/24/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BSRC News and Ratings via Email

Sign-up to receive the latest news and ratings for BSRC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

BioSolar (OTCMKTS:BSRC) Frequently Asked Questions

How has BioSolar's stock price been impacted by COVID-19?

BioSolar's stock was trading at $0.0071 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, BSRC stock has increased by 69.0% and is now trading at $0.0120.
View which stocks have been most impacted by COVID-19

When is BioSolar's next earnings date?

BioSolar is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020.
View our earnings forecast for BioSolar

Are investors shorting BioSolar?

BioSolar saw a increase in short interest during the month of August. As of August 31st, there was short interest totaling 126,200 shares, an increase of 2,075.9% from the August 15th total of 5,800 shares. Based on an average daily volume of 7,440,600 shares, the short-interest ratio is currently 0.0 days.
View BioSolar's Short Interest

Who are some of BioSolar's key competitors?

What other stocks do shareholders of BioSolar own?

Who are BioSolar's key executives?

BioSolar's management team includes the following people:
  • Dr. David D. Lee, Founder, Chairman, CEO & Acting CFO (Age 60)
  • Dr. Stanley Burton Levy, VP & CTO (Age 79)
  • Dr. Charles E. Carraher Jr., Scientific Advisor

What is BioSolar's stock symbol?

BioSolar trades on the OTCMKTS under the ticker symbol "BSRC."

How do I buy shares of BioSolar?

Shares of BSRC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is BioSolar's stock price today?

One share of BSRC stock can currently be purchased for approximately $0.01.

How big of a company is BioSolar?

BioSolar has a market capitalization of $4.33 million. BioSolar employs 1 workers across the globe.

What is BioSolar's official website?

The official website for BioSolar is www.biosolar.com.

How can I contact BioSolar?

BioSolar's mailing address is 27936 Lost Canyon Road Suite 202, Santa Clarita CA, 91387. The energy company can be reached via phone at 661-251-0001 or via email at [email protected]

This page was last updated on 9/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.